Back
Novartis AG Vs. United States Cellular Industry Stock Comparison
Buy
88
NVSEF
Novartis AG
Last Price:
98.09
Seasonality Move:
2.68%
Buy
71
USM
United States Cellular
Last Price:
44.44
Seasonality Move:
5.31%
Buy
88
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVSEF] share price is $102.14. The Score for NVSEF is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
- NVSEF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
71
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $45.10. The Score for USM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $102.14
The current trend is moderately bearish and NVSEF is experiencing selling pressure, which indicates risk of future bearish movement.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $45.10
The current trend is moderately bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 63.48 | Buy |
| Chaikin Money Flow: | -200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (93.45 - 100.09) | Buy |
| Bollinger Bands (100): | (95.56 - 104.7) | Buy |
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 67.73 | Buy |
| Chaikin Money Flow: | 133355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.95 - 42.71) | Buy |
| Bollinger Bands (100): | (34.57 - 42.69) | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.7 | Buy |
| 20-day SMA: | 97.9 | Buy |
| 50-day SMA: | 96.59 | Buy |
| 200-day SMA: | 95.5 | Buy |
| 8-day EMA: | 100.42 | Buy |
| 20-day EMA: | 98.49 | Buy |
| 50-day EMA: | 97.81 | Buy |
| 200-day EMA: | 94.77 | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.04 | Buy |
| 20-day SMA: | 39.26 | Buy |
| 50-day SMA: | 37.06 | Buy |
| 200-day SMA: | 40.1 | Buy |
| 8-day EMA: | 43.38 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 38.49 | Buy |
| 200-day EMA: | 36.73 | Buy |
Novartis AG Earnings Growth & NVSEF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.17 per share, and a decrease next year of $0.00 per share.
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.75 per share, and a decrease next year of $3.46 per share.
Novartis AG Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United States Cellular Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||